Literature DB >> 28711515

Longitudinal changes in visceral and subcutaneous adipose tissue and metabolic syndrome: Results from the Multicultural Community Health Assessment Trial (M-CHAT).

Andrew W Tu1, Karin H Humphries2, Scott A Lear3.   

Abstract

AIM: Few studies have examined whether longitudinal changes in visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT), independent of each other, are associated with the risk of developing metabolic syndrome (MetS). The objective of this study was to examine the longitudinal effects of VAT and SAT on MetS and metabolic risk factors in a multi-ethnic sample of Canadians followed for 5-years.
MATERIALS AND METHODS: In total, 598 adults of the Multicultural Community Health Assessment Trial (M-CHAT) were included in this study. Assessments of body composition using computed tomography (CT) and metabolic risk factors were conducted at baseline, 3-, and 5-years. Mixed-effects logistic regression was used to model the longitudinal effects of VAT and SAT on MetS and metabolic risk factors.
RESULTS: There were significant between-person (cross-sectional) effects such that for every 10cm2 higher VAT, the odds of MetS, high-risk fasting glucose levels and high-risk HDL-C levels significantly increased by 16% (95% CI: 9-24%), 11% (3-20%), and 7% (0-14%) respectively. Significant within-person (longitudinal) effects were also found such that for every 10cm2 increase in VAT the odds of MetS and high-risk triglyceride levels significantly increased by 23% (9-39%) and 30% (14-48%), respectively. Cross-sectional or longitudinal changes in SAT were not associated with MetS or metabolic risk factors.
CONCLUSIONS: This study found a direct relationship between longitudinal change in VAT and MetS risk independent of changes in SAT. Clinical practice should focus on the reduction of VAT to improve cardiovascular health outcomes.
Copyright © 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Longitudinal study; Metabolic syndrome; Subcutaneous adipose tissue; Visceral adipose tissue

Mesh:

Year:  2017        PMID: 28711515     DOI: 10.1016/j.dsx.2017.07.022

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  6 in total

1.  Changes in central adipose tissue after switching to integrase inhibitors.

Authors:  Paula Debroy; Han Feng; Hongyu Miao; Jovana Milic; Guido Ligabue; Stefano Draisci; Giulia Besutti; Federica Carli; Marianna Menozzi; Cristina Mussini; Giovanni Guaraldi; Jordan E Lake
Journal:  HIV Res Clin Pract       Date:  2021-01-18

2.  Human Macrophages Preferentially Infiltrate the Superficial Adipose Tissue.

Authors:  Giuseppe Cappellano; Evi M Morandi; Johannes Rainer; Philipp Grubwieser; Katharina Heinz; Dolores Wolfram; David Bernhard; Susanne Lobenwein; Gerhard Pierer; Christian Ploner
Journal:  Int J Mol Sci       Date:  2018-05-08       Impact factor: 5.923

3.  Abdominal visceral and subcutaneous adipose tissues in association with cardiometabolic risk in children and adolescents: the China Child and Adolescent Cardiovascular Health (CCACH) study.

Authors:  Yinkun Yan; Junting Liu; Xiaoyuan Zhao; Hong Cheng; Guimin Huang; Jie Mi
Journal:  BMJ Open Diabetes Res Care       Date:  2019-12-08

4.  Investigation of Physiological Swelling on Conductivity Distribution in Lower Leg Subcutaneous Tissue by Electrical Impedance Tomography.

Authors:  R Ogawa; M R Baidillah; S Akita; M Takei
Journal:  J Electr Bioimpedance       Date:  2020-05-14

5.  Magnetic Resonance Imaging Assessment of Abdominal Ectopic Fat Deposition in Correlation With Cardiometabolic Risk Factors.

Authors:  Qin-He Zhang; Lu-Han Xie; Hao-Nan Zhang; Jing-Hong Liu; Ying Zhao; Li-Hua Chen; Ye Ju; An-Liang Chen; Nan Wang; Qing-Wei Song; Li-Zhi Xie; Ai-Lian Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-30       Impact factor: 5.555

6.  Abdominal visceral and subcutaneous adipose tissue and associations with cardiometabolic risk in Inuit, Africans and Europeans: a cross-sectional study.

Authors:  Pernille Falberg Rønn; Gregers Stig Andersen; Torsten Lauritzen; Dirk Lund Christensen; Mette Aadahl; Bendix Carstensen; Niels Grarup; Marit Eika Jørgensen
Journal:  BMJ Open       Date:  2020-09-14       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.